Emergency departments are required by law to treat anyone who comes through the door. But the financial model behind that guarantee is under strain. 

In this episode of "Podnosis," Fierce Healthcare and Life Sciences Editor-in-Chief Ayla Ellison talks with Tony Cirillo, M.D., president of the American College of Emergency Physicians, about the business of emergency medicine—who pays, how much, and what happens when the math stops working.

To learn more about the topics in this episode: 
Without new financial support, emergency departments, physicians struggle to meet rising demand: RAND
Op-ed: What if the ER is the emergency?
Op-ed: Emergency physicians are holding the line, but we can't do it alone

Emergency departments are required by law to treat anyone who comes through the door. But the financial model behind that guarantee is under strain.&nbsp;
In this episode of "Podnosis," Fierce Healthcare and Life Sciences Editor-in-Chief Ayla Ellison talks with Tony Cirillo, M.D., president of the American College of Emergency Physicians, about the business of emergency medicine&mdash;who pays, how much, and what happens when the math stops working.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/providers/without-new-financial-support-emergency-departments-physicians-struggle-meet-rising">Without new financial support, emergency departments, physicians struggle to meet rising demand: RAND</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/op-ed-what-if-er-emergency">Op-ed: What if the ER is the emergency?</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/op-ed-emergency-physicians-are-holding-line-we-cant-do-it-alone">Op-ed: Emergency physicians are holding the line, but we can't do it alone</a></li>
</ul>

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Podnosis

Podnosis: the pulse of the healthcare industry. Every week, journalists from Fierce Healthcare dive into some of the industry’s biggest trends. We talk to the experts about what’s important now so you can prep for the future. Hear about all things healthcare, from physician practices to hospital chains and insurance giants—and those that mix all three—plus the tech they use, disruptors looking to compete and people moving the sector forward. Follow Podnosis on Apple Podcasts, Spotify, Amazon or wherever you get your podcasts.

Inside the economics of emergency medicine

How many doctors are using AI tools in a healthcare setting? It’s a question everyone wants answered, and one that’s impossible to pin down exactly. But recent data may offer a clue.

Wolters Kluwer, which creates evidence-based clinical decision support tools for physicians, conducted a survey of more than 500 health professionals, finding that 40% have encountered unauthorized AI tools at work and 17% have used them. But a blanket ban may not necessarily be the best approach. The unauthorized use of AI tools is referred to as “shadow AI” in a report on the findings.

To explain what organizations can do to protect themselves, their providers and their patients, Senior Writer Anastassia Gliadkovskaya speaks with Alex Tyrrell, CTO of Wolters Kluwer Health.

To learn more about the topics in this episode: 
57% of healthcare professionals have encountered or used unauthorized AI tools at work
ECRI flags misuse of AI chatbots as a top health tech hazard in 2026
Microsoft unveils Copilot Health as an AI health companion for consumers
OpenEvidence clinches $250M series D as AI platform sees explosive growth with doctors
Some doctors are using public AI chatbots like ChatGPT in clinical decisions. Is it safe?

How many doctors are using AI tools in a healthcare setting? It&rsquo;s a question everyone wants answered, and one that&rsquo;s impossible to pin down exactly. But recent data may offer a clue.
Wolters Kluwer, which creates evidence-based clinical decision support tools for physicians, conducted a survey of more than 500 health professionals, finding that 40% have encountered unauthorized AI tools at work and 17% have used them. But a blanket ban may not necessarily be the best approach. The unauthorized use of AI tools is referred to as &ldquo;shadow AI&rdquo; in a report on the findings.
To explain what organizations can do to protect themselves, their providers and their patients, Senior Writer Anastassia Gliadkovskaya speaks with Alex Tyrrell, CTO of Wolters Kluwer Health.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/digital-health/nearly-fifth-healthcare-professionals-use-unauthorized-ai-tools-work">57% of healthcare professionals have encountered or used unauthorized AI tools at work</a></li>
<li><a href="https://www.fiercehealthcare.com/health-tech/ecri-flags-misuse-ai-chatbots-top-health-tech-hazard-2026">ECRI flags misuse of AI chatbots as a top health tech hazard in 2026</a></li>
<li><a href="https://www.fiercehealthcare.com/ai-and-machine-learning/microsoft-unveils-copilot-health-ai-health-companion-consumers">Microsoft unveils Copilot Health as an AI health companion for consumers</a></li>
<li><a href="https://www.fiercehealthcare.com/ai-and-machine-learning/openevidence-clinches-250m-series-d-rapidly-growing-its-reach-doctors">OpenEvidence clinches $250M series D as AI platform sees explosive growth with doctors</a></li>
<li><a href="https://www.fiercehealthcare.com/special-reports/some-doctors-are-using-public-generative-ai-tools-chatgpt-clinical-decisions-it">Some doctors are using public AI chatbots like ChatGPT in clinical decisions. Is it safe?</a></li>
</ul>

Shadow AI: Dos and don’ts for healthcare orgs 

The COVID-19 pandemic spotlighted burnout in healthcare. While not new, the challenge was compounded by the toll of caring for patients on the frontlines. Burnout rates have swelled since then, and addressing them is not simple.

A recent Johnson & Johnson survey of more than 1,500 surgeons across five countries found that half experience burnout, and 43% have seriously considered leaving surgery.

To understand the implications of the findings, Senior Writer Anastassia Gliadkovskaya speaks with Africa Wallace, M.D., vice president of medical affairs, surgery and medtech at Johnson & Johnson.

She also speaks with Angela Chaudhari, M.D., associate professor and vice chair of faculty affairs at Northwestern University Feinberg School of Medicine. Chaudhari discusses a clinician peer support initiative she directs at Northwestern and the role it plays in mitigating burnout.

To learn more about the topics in this episode: 
Nearly all doctors suffer burnout, survey finds, but many cautiously hopeful that AI could help
5 years later: A look back at the COVID-19 pandemic and how healthcare has changed

The COVID-19 pandemic spotlighted burnout in healthcare. While not new, the challenge was compounded by the toll of caring for patients on the frontlines. Burnout rates have swelled since then, and addressing them is not simple.
A recent Johnson &amp; Johnson survey of more than 1,500 surgeons across five countries found that half experience burnout, and 43% have seriously considered leaving surgery.
To understand the implications of the findings, Senior Writer Anastassia Gliadkovskaya speaks with Africa Wallace, M.D., vice president of medical affairs, surgery and medtech at Johnson &amp; Johnson.
She also speaks with Angela Chaudhari, M.D., associate professor and vice chair of faculty affairs at Northwestern University Feinberg School of Medicine. Chaudhari discusses a clinician peer support initiative she directs at Northwestern and the role it plays in mitigating burnout.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercehealthcare.com/providers/nearly-all-doctors-suffer-burnout-survey-finds-many-cautiously-hopeful-about-use-ai">Nearly all doctors suffer burnout, survey finds, but many cautiously hopeful that AI could help</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/five-years-covid-19-pandemic-how-has-healthcare-changed">5 years later: A look back at the COVID-19 pandemic and how healthcare has changed</a></li>
</ul>

Clinicians are burnt out. Peer support can help

Rare diseases, defined in the U.S. as conditions affecting fewer than 200,000 people, can take years, if not decades, to diagnose. About 10,000 rare diseases affect 30 million Americans, and half of those patients are children.

What if rare diseases could be identified early and treated proactively before they progress? That is becoming more possible thanks to advances in genetic testing. One company, GeneDx, is on a mission to address diagnostic challenges through faster, more affordable genome testing.

To explain the evolution of this technology, how it is changing lives and where it may go in the future, Senior Writer Anastassia Gliadkovskaya speaks with GeneDx CEO Katherine Stueland.

To learn more about the topics in this episode: 
RNA sequencing spots 40% more cancer mutations in children than standard genetic tests: study
Regeneron, Illumina and more back Truveta for 10M genome sequencing project
Survey: Many rare disease patients struggle to navigate care

Rare diseases, defined in the U.S. as conditions affecting fewer than 200,000 people, can take years, if not decades, to diagnose. About 10,000 rare diseases affect 30 million Americans, and half of those patients are children.
What if rare diseases could be identified early and treated proactively before they progress? That is becoming more possible thanks to advances in genetic testing. One company, GeneDx, is on a mission to address diagnostic challenges through faster, more affordable genome testing.
To explain the evolution of this technology, how it is changing lives and where it may go in the future, Senior Writer Anastassia Gliadkovskaya speaks with GeneDx CEO Katherine Stueland.
To learn more about the topics in this episode:&nbsp;
<ul>
<li><a href="https://www.fiercebiotech.com/medtech/rna-sequencing-spots-40-more-cancer-mutations-children-than-standard-genetic-tests-study">RNA sequencing spots 40% more cancer mutations in children than standard genetic tests: study</a></li>
<li><a href="https://www.fiercebiotech.com/medtech/jpm25-regeneron-illumina-and-more-back-truveta-10m-genome-sequencing-project">Regeneron, Illumina and more back Truveta for 10M genome sequencing project</a></li>
<li><a href="https://www.fiercehealthcare.com/providers/pantherx-survey-many-rare-disease-patients-struggle-navigate-system">Survey: Many rare disease patients struggle to navigate care</a></li>
</ul>

Inside the economics of emergency medicine

In 1 playlist(s)

Podnosis

Social links

Follow podcast

Recent clips